報價延遲最少15分鐘:2025/09/17 06:07 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
65.16
|
|
|
| 價值評估 |
|
盈利(現時/預測)
2.04/4.39
|
|
企業價值
15.57B
|
| 資產負債 |
|
每股賬面淨值
42.01
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
3.90B
|
|
每股收益
17.68
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/09/17 06:07 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical,founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market. |
